Pharmaceutical Treatment of Plantar Fasciitis

NewsBot · Mar 30, 2018

Members do not see these Ads. Sign Up.
Prevalence and Pharmaceutical Treatment of Plantar Fasciitis in United States Adults.
Nahin RL
J Pain. 2018 Mar 26. pii: S1526-5900(18)30112-3. doi: 10.1016/j.jpain.2018.03.003.

This study provides prevalence estimates of plantar fasciitis in United States (U.S.) adults, as well as the types and frequencies of pharmaceutical treatment specifically for this pain. Data are from the 2013 National Health and Wellness Survey, a large (n=75,000) internet panel survey designed to approximate the adult U.S.

POPULATION:
Strengths of associations are determined using multivariable logistic regression. It was estimated that 0.85% (95% CI: 0.77 - 0.92) of the sample reported diagnosed plantar fasciitis with pain in the last month. Higher prevalence of plantar fasciitis was seen in females (1.19%) [referent] versus males (0.47%), in those aged 45-64 (1.33%) versus those aged 18-44 (0.53%) [referent], and in the obese (1.48%) versus those with a body mass less than 25 (0.29%) [referent]. Prescription medications for pain were used by 41.04% of plantar fasciitis respondents, but only 6.31% attributed this use specifically to plantar fasciitis pain. NSAIDs (4.01%) and opioids (2.21%) were the most prevalent prescription drugs used specifically for plantar fasciitis pain. Almost 70% of individuals with plantar fasciitis used over-the-counter (OTC) analgesics for general pain management, with OTC NSAIDs being used by 49.47% and acetaminophen by 26.93% of respondents. Individuals diagnosed by medical specialists had twice the odds of using prescription drugs as those diagnosed by other providers (OR= 2.12; 95% CI: 1.01-4.46). Non-Hispanic blacks were more likely to use prescription pain medications specifically for plantar fasciitis pain than Non-Hispanic whites (OR = 3.02; 95% CI: 1.05-8.70). These findings will help inform healthcare providers and policy makers whether the current use of pharmaceutical treatments for plantar fasciitis reflect evidence-based treatment guidelines.
Click to expand...

NewsBot The Admin that posts the news.

Proof of concept study on the biopharmaceutical SF-1019 for diabetic foot ulcers

Health professionals and the pharmaceutical industry

Proprioceptive Insoles in Treatment of TMD

Phytoterpenes for the Treatment of Plantar Fasciitis

Nail Lacquer in the Treatment of Nail Diseases

Patients Questions Over Bunion Treatments

Paraffin wax treatments

Share This Page